Corinne Austin
Family · Spokane Valley, WANPI 1508610445
Payments from drug & device makers
Across 60 payments — averaging $21.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$281
- Novo Nordisk$273
- Exact Sciences$131
- Amgen$113
- Boehringer Ingelheim$66
- Lilly USA, LLC$63
- plus $344 from 12 others
What the payments were for
- Food & beverage$1,270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 15 | $281 |
| Novo Nordisk | 13 | $273 |
| Exact Sciences | 5 | $131 |
| Amgen | 5 | $113 |
| Boehringer Ingelheim | 3 | $66 |
| Lilly USA, LLC | 2 | $63 |
| Corcept Therapeutics | 3 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Antares Pharma, Inc. | 2 | $42 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| Edwards Lifesciences | 1 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Inspire Medical Systems, Inc. | 1 | $23 |
| Phadia US Inc. | 1 | $20 |
| Recordati_rare_diseases_inc. | 1 | $18 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
| Coopersurgical, Inc. | 1 | $15 |
How this compares
$1,270 in reported general payments places this provider in the 80th percentile of 1,706 family providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $304 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $173 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 12 | $161 |
| Omeprazole | 12 | $159 |
| Rosuvastatin Calcium | 18 | $147 |
| Atorvastatin Calcium | 21 | $134 |
| Lisinopril | 32 | $118 |
| Levothyroxine Sodium | 27 | $115 |
| Amlodipine Besylate | 27 | $112 |
| Losartan Potassium | 21 | $65 |
Paid to pharmacies, not to this prescriber.
Other family in Spokane Valley
- Brittanee WorthySpokane Valley$15K
- Jaime KeySpokane Valley$9K
- Carolyn CampaSpokane Valley$8K
- Katherine ReynoldsSpokane Valley$8K
- Patric SchineCentralia$842K
- Sharla PetersonKenmore$192K
- Zelda SwainSpokane$83K
- Savannah MorganRenton$76K
- Kevan PettersonSeattle$56K
- Kelly McFeeSunnyside$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.